Search Results - "Papneja, N"
-
1
A review of cancer immunotherapy: from the past, to the present, to the future
Published in Current oncology (Toronto) (01-04-2020)“…Compared with previous standards of care (including chemotherapy, radiotherapy, and surgery), cancer immunotherapy has brought significant improvements for…”
Get full text
Journal Article -
2
-
3
701P - Outcomes of first-line FOLFIRINOX (FFX) versus gemcitabine and nab-paclitaxel (GN) in patients with advanced pancreatic cancer: Multi-Institutional Canadian sites experience
Published in Annals of oncology (01-10-2019)“…FOLFIRINOX (FFX) and Gemcitabine with nab-Paclitaxel (GN) are both proven to be superior to Gemcitabine in first line treatment for advanced pancreatic cancer…”
Get full text
Journal Article -
4
701POutcomes of first-line FOLFIRINOX (FFX) versus gemcitabine and nab-paclitaxel (GN) in patients with advanced pancreatic cancer: Multi-Institutional Canadian sites experience
Published in Annals of oncology (01-10-2019)“…Abstract Background FOLFIRINOX (FFX) and Gemcitabine with nab-Paclitaxel (GN) are both proven to be superior to Gemcitabine in first line treatment for…”
Get full text
Journal Article -
5
410P Ipilimumab efficacy and safety profile in metastatic melanoma in Saskatchewan
Published in Annals of oncology (01-12-2016)Get full text
Journal Article -
6
410P Ipilimumab efficacy and safety profile in metastatic melanoma in Saskatchewan
Published in Annals of oncology (01-12-2016)Get full text
Journal Article -
7